Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 MGMT promoter methylation status in anaplastic meningiomas.

Literature DB >> 20449628

MGMT promoter methylation status in anaplastic meningiomas.

Benjamin Brokinkel, Bernhard R Fischer, Susanne Peetz-Dienhart, Heinrich Ebel, Abolghassem Sepehrnia, Burckhard Rama, Friedrich K Albert, Walter Stummer, Werner Paulus, Martin Hasselblatt.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2010 PMID： 20449628 DOI： 10.1007/s11060-010-0202-0

Source DB: PubMed Journal: J Neurooncol ISSN： 0167-594X Impact factor: 4.130

× No keyword cloud information.

8 in total

Review 1. Diagnosis and treatment of atypical and anaplastic meningiomas: a review.

Authors: Ashok Modha; Philip H Gutin
Journal: Neurosurgery Date: 2005-09 Impact factor: 4.654

Review 2. MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

Authors: Michael Weller; Roger Stupp; Guido Reifenberger; Alba A Brandes; Martin J van den Bent; Wolfgang Wick; Monika E Hegi
Journal: Nat Rev Neurol Date: 2009-12-08 Impact factor: 42.937

3. Methylation status of MGMT gene promoter in meningiomas.

Authors: Paula de Robles; John McIntyre; Sanjog Kalra; Gloria Roldán; Gregory Cairncross; Peter Forsyth; Tony Magliocco; Mark Hamilton; Jacob Easaw
Journal: Cancer Genet Cytogenet Date: 2008-11

Review 4. Chemoradiotherapy in malignant glioma: standard of care and future directions.

Authors: Roger Stupp; Monika E Hegi; Mark R Gilbert; Arnab Chakravarti
Journal: J Clin Oncol Date: 2007-09-10 Impact factor: 44.544

5. Temozolomide for treatment-resistant recurrent meningioma.

Authors: Marc C Chamberlain; Denice D Tsao-Wei; Susan Groshen
Journal: Neurology Date: 2004-04-13 Impact factor: 9.910

6. Aberrant MGMT (O6-methylguanine-DNA methyltransferase) promoter methylation in choroid plexus tumors.

Authors: Martin Hasselblatt; Jörg Mühlisch; Brigitte Wrede; Birgit Kallinger; Astrid Jeibmann; Ove Peters; Tezer Kutluk; Johannes E A Wolff; Werner Paulus; Michael C Frühwald
Journal: J Neurooncol Date: 2008-09-16 Impact factor: 4.130

7. Temozolomide preferentially depletes cancer stem cells in glioblastoma.

Authors: Dagmar Beier; Stefanie Röhrl; Deepu R Pillai; Stefanie Schwarz; Leoni A Kunz-Schughart; Petra Leukel; Martin Proescholdt; Alexander Brawanski; Ulrich Bogdahn; Ariane Trampe-Kieslich; Bernd Giebel; Jörg Wischhusen; Guido Reifenberger; Peter Hau; Christoph P Beier
Journal: Cancer Res Date: 2008-07-15 Impact factor: 12.701

8. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.

Authors: M Josefa Bello; Cinthia Amiñoso; Isabel Lopez-Marin; Dolores Arjona; Pilar Gonzalez-Gomez; M Eva Alonso; Jesus Lomas; Jose M de Campos; M Elena Kusak; Jesus Vaquero; Alberto Isla; Manuel Gutierrez; Jose L Sarasa; Juan A Rey
Journal: Acta Neuropathol Date: 2004-09-10 Impact factor: 17.088

8 in total

6 in total

1. Lack of MGMT promoter hypermethylation in hemangiopericytomas of the central nervous system.

Authors: Benjamin Brokinkel; Susanne Peetz-Dienhart; Kathy Keyvani; Walter Stummer; Werner Paulus; Martin Hasselblatt
Journal: J Neurooncol Date: 2012-08-23 Impact factor: 4.130

2. Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma.

Authors: Ioannis Panagopoulos; Ludmila Gorunova; Henning Leske; Pitt Niehusmann; Lene E Johannessen; Julie Staurseth; Nina Øino; Torstein R Meling; Sverre Heim; Francesca Micci; Petter Brandal
Journal: Cancer Genomics Proteomics Date: 2018 Sep-Oct Impact factor: 4.069